Welcome to Diazyme Laboratories - Innovating Healthcare with Advanced Diagnostics

Diazyme Laboratories Inc., a leader in innovative diagnostic solutions, is dedicated to advancing healthcare through proprietary enzyme and immunoassay technologies. We specialize in the research and development, manufacture, and distribution of accurate, high-quality diagnostic reagents that can be used on user-friendly automated analyzers. With a commitment to excellence, our cutting-edge products are trusted by healthcare professionals worldwide.

New Arrivals

ApoE4 Test Kit COMING SOON

ApoE4 Test Kit

Coming Soon! INTENDED USE: The Diazyme ApoE4 Test Kit is designed to qualitatively determine the presence of ApoE4 antigens in human plasma. The test allows to determine if a sample is ApoE4 negative...

Request Quote
pTau-217 CLIA KIT COMING SOON

pTau-217 CLIA KIT

Coming Soon! INTENDED USE: Diazyme pTau-217 CLIA Kit is for the quantitative determination of Phosphorylated Tau 217 (pTau-217) concentration in EDTA plasma on chemiluminescence analyzer. USA: For...

Request Quote
AMYLOID-β42 CLIA KIT COMING SOON

AMYLOID-β42 CLIA KIT

Coming Soon! INTENDED USE: Diazyme Aβ42 CLIA Kit is for the quantitative determination of Aβ42 concentration in EDTA plasma on chemiluminescence analyzer. USA: For Research Use Only. Not for use in...

Request Quote
AMYLOID-β40 CLIA KIT COMING SOON

AMYLOID-β40 CLIA Kit

Coming Soon! INTENDED USE: Diazyme Aβ40 CLIA Kit is for the quantitative determination of Aβ40 concentration in EDTA plasma on chemiluminescence analyzer. USA: For Research Use Only. Not for use in...

Request Quote
pTau-181 Assay COMING SOON

pTau-181 CLIA KIT

Coming Soon! INTENDED USE: Diazyme pTau-181 CLIA Kit is for the quantitative determination of Phosphorylated Tau 181 (pTau-181) concentration in EDTA plasma on chemiluminescence analyzer. USA: For...

Request Quote

Products View all

Recent Announcements

Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay

17th Jun 2026

POWAY, CA – June 17, 2026 – Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug A…
read more

Diazyme Laboratories, Inc. Acquires Carolina Liquid Chemistries Corp.

1st Jun 2026

POWAY, CA – June 1, 2026 – Diazyme Laboratories, Inc. announced today that it has acquired the busin…
read more

Webinar Recap: Kappa and Lambda Free Light Chains in Plasma Cell Disorders

22nd Apr 2026

Abbott recently hosted a webinar exploring the clinical role of kappa and lambda free light chain te…
read more